Mortality risk among new onset injection drug users

David Vlahov, Cun Iin Wang, Noya Galai, Joseph Bareta, Shruti Hemendra Mehta, Steffanie A. Strathdee, Kenrad Edwin Nelson

Research output: Contribution to journalArticle

Abstract

Aims: To characterize mortality experience among those who only recently started injection. Design: Prospective study. Setting: Independent study clinic within high drug use neighborhoods. Participants In 1988-1989, we enrolled 256 adult injection drug users (IDUs) recruited through street outreach who had initiated injection within the prior 2 years. Measurements: Consenting participants underwent venipuncture for HIV antibody testing and interviews. We prospectively ascertained date and cause of death through follow-up contact and registry linkages. Analyses included standardized mortality ratios (SMRs) with local, state and national mortality data, adjusted for age, gender and race. Findings: Baseline median age was 30 years, 70% were male, 95% were African-American and 90% injected within the prior 6 months. We identified 69 deaths through October 2000; mortality rate was 3,3/100 person-years. The adjusted SMR with the USA (and Baltimore) as the reference for IDUs was 4.40 (2.43) for 1991-1992, which increased to 8.12 (4.13) by 1993-1994, decreased to 4.43 (2.13) by 1997-1998 and increased slightly to 5.35 (2.79) during 1999-2000. Excluding HIV-related mortality, SMRs remained elevated. Decline in SMRs was not linked to drug abuse treatment. Conclusions These data demonstrate excess mortality among new-onset IDUs compared with demographically similar peers in the general population, indicating the need for interventions to prevent premature death among young IDUs.

Original languageEnglish (US)
Pages (from-to)946-954
Number of pages9
JournalAddiction
Volume99
Issue number8
DOIs
StatePublished - Aug 2004

Fingerprint

Drug Users
Injections
Mortality
HIV Antibodies
Baltimore
Premature Mortality
Phlebotomy
African Americans
Substance-Related Disorders
Registries
Cause of Death
HIV
Prospective Studies
Interviews
Pharmaceutical Preparations
Population

Keywords

  • Bisexual
  • Homosexual
  • Human immunodeficiency virus
  • Incidence
  • Injection drug use
  • Mortality

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Mortality risk among new onset injection drug users. / Vlahov, David; Wang, Cun Iin; Galai, Noya; Bareta, Joseph; Mehta, Shruti Hemendra; Strathdee, Steffanie A.; Nelson, Kenrad Edwin.

In: Addiction, Vol. 99, No. 8, 08.2004, p. 946-954.

Research output: Contribution to journalArticle

Vlahov, David ; Wang, Cun Iin ; Galai, Noya ; Bareta, Joseph ; Mehta, Shruti Hemendra ; Strathdee, Steffanie A. ; Nelson, Kenrad Edwin. / Mortality risk among new onset injection drug users. In: Addiction. 2004 ; Vol. 99, No. 8. pp. 946-954.
@article{e0427d7961c242dcb90ee6c9e71aef5d,
title = "Mortality risk among new onset injection drug users",
abstract = "Aims: To characterize mortality experience among those who only recently started injection. Design: Prospective study. Setting: Independent study clinic within high drug use neighborhoods. Participants In 1988-1989, we enrolled 256 adult injection drug users (IDUs) recruited through street outreach who had initiated injection within the prior 2 years. Measurements: Consenting participants underwent venipuncture for HIV antibody testing and interviews. We prospectively ascertained date and cause of death through follow-up contact and registry linkages. Analyses included standardized mortality ratios (SMRs) with local, state and national mortality data, adjusted for age, gender and race. Findings: Baseline median age was 30 years, 70{\%} were male, 95{\%} were African-American and 90{\%} injected within the prior 6 months. We identified 69 deaths through October 2000; mortality rate was 3,3/100 person-years. The adjusted SMR with the USA (and Baltimore) as the reference for IDUs was 4.40 (2.43) for 1991-1992, which increased to 8.12 (4.13) by 1993-1994, decreased to 4.43 (2.13) by 1997-1998 and increased slightly to 5.35 (2.79) during 1999-2000. Excluding HIV-related mortality, SMRs remained elevated. Decline in SMRs was not linked to drug abuse treatment. Conclusions These data demonstrate excess mortality among new-onset IDUs compared with demographically similar peers in the general population, indicating the need for interventions to prevent premature death among young IDUs.",
keywords = "Bisexual, Homosexual, Human immunodeficiency virus, Incidence, Injection drug use, Mortality",
author = "David Vlahov and Wang, {Cun Iin} and Noya Galai and Joseph Bareta and Mehta, {Shruti Hemendra} and Strathdee, {Steffanie A.} and Nelson, {Kenrad Edwin}",
year = "2004",
month = "8",
doi = "10.1111/j.1360-0443.2004.00780.x",
language = "English (US)",
volume = "99",
pages = "946--954",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Mortality risk among new onset injection drug users

AU - Vlahov, David

AU - Wang, Cun Iin

AU - Galai, Noya

AU - Bareta, Joseph

AU - Mehta, Shruti Hemendra

AU - Strathdee, Steffanie A.

AU - Nelson, Kenrad Edwin

PY - 2004/8

Y1 - 2004/8

N2 - Aims: To characterize mortality experience among those who only recently started injection. Design: Prospective study. Setting: Independent study clinic within high drug use neighborhoods. Participants In 1988-1989, we enrolled 256 adult injection drug users (IDUs) recruited through street outreach who had initiated injection within the prior 2 years. Measurements: Consenting participants underwent venipuncture for HIV antibody testing and interviews. We prospectively ascertained date and cause of death through follow-up contact and registry linkages. Analyses included standardized mortality ratios (SMRs) with local, state and national mortality data, adjusted for age, gender and race. Findings: Baseline median age was 30 years, 70% were male, 95% were African-American and 90% injected within the prior 6 months. We identified 69 deaths through October 2000; mortality rate was 3,3/100 person-years. The adjusted SMR with the USA (and Baltimore) as the reference for IDUs was 4.40 (2.43) for 1991-1992, which increased to 8.12 (4.13) by 1993-1994, decreased to 4.43 (2.13) by 1997-1998 and increased slightly to 5.35 (2.79) during 1999-2000. Excluding HIV-related mortality, SMRs remained elevated. Decline in SMRs was not linked to drug abuse treatment. Conclusions These data demonstrate excess mortality among new-onset IDUs compared with demographically similar peers in the general population, indicating the need for interventions to prevent premature death among young IDUs.

AB - Aims: To characterize mortality experience among those who only recently started injection. Design: Prospective study. Setting: Independent study clinic within high drug use neighborhoods. Participants In 1988-1989, we enrolled 256 adult injection drug users (IDUs) recruited through street outreach who had initiated injection within the prior 2 years. Measurements: Consenting participants underwent venipuncture for HIV antibody testing and interviews. We prospectively ascertained date and cause of death through follow-up contact and registry linkages. Analyses included standardized mortality ratios (SMRs) with local, state and national mortality data, adjusted for age, gender and race. Findings: Baseline median age was 30 years, 70% were male, 95% were African-American and 90% injected within the prior 6 months. We identified 69 deaths through October 2000; mortality rate was 3,3/100 person-years. The adjusted SMR with the USA (and Baltimore) as the reference for IDUs was 4.40 (2.43) for 1991-1992, which increased to 8.12 (4.13) by 1993-1994, decreased to 4.43 (2.13) by 1997-1998 and increased slightly to 5.35 (2.79) during 1999-2000. Excluding HIV-related mortality, SMRs remained elevated. Decline in SMRs was not linked to drug abuse treatment. Conclusions These data demonstrate excess mortality among new-onset IDUs compared with demographically similar peers in the general population, indicating the need for interventions to prevent premature death among young IDUs.

KW - Bisexual

KW - Homosexual

KW - Human immunodeficiency virus

KW - Incidence

KW - Injection drug use

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=7444252679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444252679&partnerID=8YFLogxK

U2 - 10.1111/j.1360-0443.2004.00780.x

DO - 10.1111/j.1360-0443.2004.00780.x

M3 - Article

VL - 99

SP - 946

EP - 954

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 8

ER -